Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (7): 682-686.DOI: 10.3969/j.issn.1673-8640.2024.07.011
Previous Articles Next Articles
WANG Tiankai1, LIU Lin1, JIN Peipei2, WANG Fang2, DING Ning1()
Received:
2024-05-02
Revised:
2024-06-11
Online:
2024-07-30
Published:
2024-07-31
CLC Number:
WANG Tiankai, LIU Lin, JIN Peipei, WANG Fang, DING Ning. Clinical value of new neutrophil parameter NEU-X,NEU-Y and NEU-Z in diagnosis of sepsis[J]. Laboratory Medicine, 2024, 39(7): 682-686.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.07.011
组别 | 例数 | NEU-X | NEU-Y | NEU-Z |
---|---|---|---|---|
败血症组 | 55 | 373.40(346.70,394.40)*# | 535.70(509.40,570.80)*# | 1 758.10(1 698.50,1 833.50) |
非败血症组 | 73 | 350.70(333.40,373.80)# | 487.80(472.15,512.55)# | 1 788.80(1 687.40,1 841.80) |
健康对照组 | 175 | 320.10(307.70,336.90) | 444.60(430.80,462.40) | 1 764.00(1 707.70,1 813.10) |
F值 | 86.42 | 161.4 | 0.39 | |
P值 | <0.001 | <0.001 | 0.68 | |
组别 | CRP/mg·L-1 | WBC/(×109·L-1) | NEUT#/(×109·L-1) | |
败血症组 | 63.00(35.00,95.00)# | 9.00(6.57,14.79)# | 7.16(4.80,12.91)# | |
非败血症组 | 50.00(15.00,96.00)# | 8.81(6.06,12.95)# | 6.08(4.30,10.95)# | |
健康对照组 | 6.00(4.00,7.00) | 5.63(4.85,6.68) | 3.23(2.66,4.03) | |
F值 | 128.7 | 63.09 | 85.39 | |
P值 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | NEU-X | NEU-Y | NEU-Z |
---|---|---|---|---|
败血症组 | 55 | 373.40(346.70,394.40)*# | 535.70(509.40,570.80)*# | 1 758.10(1 698.50,1 833.50) |
非败血症组 | 73 | 350.70(333.40,373.80)# | 487.80(472.15,512.55)# | 1 788.80(1 687.40,1 841.80) |
健康对照组 | 175 | 320.10(307.70,336.90) | 444.60(430.80,462.40) | 1 764.00(1 707.70,1 813.10) |
F值 | 86.42 | 161.4 | 0.39 | |
P值 | <0.001 | <0.001 | 0.68 | |
组别 | CRP/mg·L-1 | WBC/(×109·L-1) | NEUT#/(×109·L-1) | |
败血症组 | 63.00(35.00,95.00)# | 9.00(6.57,14.79)# | 7.16(4.80,12.91)# | |
非败血症组 | 50.00(15.00,96.00)# | 8.81(6.06,12.95)# | 6.08(4.30,10.95)# | |
健康对照组 | 6.00(4.00,7.00) | 5.63(4.85,6.68) | 3.23(2.66,4.03) | |
F值 | 128.7 | 63.09 | 85.39 | |
P值 | <0.001 | <0.001 | <0.001 |
组别 | 例数/例 | NEU-X | NEU-Y | NEU-Z |
---|---|---|---|---|
革兰阴性菌感染组 | 34 | 373.80(352.28,395.15) | 554.00(520.80,595.25) | 1 759.50(1 705.85,1 833.93) |
革兰阳性菌感染组 | 15 | 378.60(345.80,394.40) | 532.40(490.30,557.90) | 1 719.50(1 643.60,1 842.20) |
真菌感染组 | 6 | 342.75(316.50,386.68) | 493.60(456.13,530.00)* | 1 768.40(1 678.95,1 810.93) |
F值 | 1.16 | 3.60 | 2.21 | |
P值 | 0.32 | 0.02 | 0.12 |
组别 | 例数/例 | NEU-X | NEU-Y | NEU-Z |
---|---|---|---|---|
革兰阴性菌感染组 | 34 | 373.80(352.28,395.15) | 554.00(520.80,595.25) | 1 759.50(1 705.85,1 833.93) |
革兰阳性菌感染组 | 15 | 378.60(345.80,394.40) | 532.40(490.30,557.90) | 1 719.50(1 643.60,1 842.20) |
真菌感染组 | 6 | 342.75(316.50,386.68) | 493.60(456.13,530.00)* | 1 768.40(1 678.95,1 810.93) |
F值 | 1.16 | 3.60 | 2.21 | |
P值 | 0.32 | 0.02 | 0.12 |
项目 | 曲线下面积(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% |
---|---|---|---|---|
NEU-X | 0.681 8(0.588 9~0.774 8) | 366.00 | 71.23 | 60.00 |
NEU-Y | 0.810 3(0.731 0~0.889 7)* | 508.90 | 72.60 | 76.36 |
NEU-Z | 0.535 0(0.433 8~0.636 2) | 1 757.50 | 57.53 | 49.09 |
CRP | 0.578 5(0.480 0~0.676 9) | 61.00 g·L-1 | 61.64 | 56.36 |
WBC计数 | 0.548 1(0.444 4~0.651 7) | 10.08×109·L-1 | 64.38 | 47.27 |
NEUT# | 0.562 8(0.459 5~0.666 0) | 7.24×109·L-1 | 60.27 | 49.09 |
项目 | 曲线下面积(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% |
---|---|---|---|---|
NEU-X | 0.681 8(0.588 9~0.774 8) | 366.00 | 71.23 | 60.00 |
NEU-Y | 0.810 3(0.731 0~0.889 7)* | 508.90 | 72.60 | 76.36 |
NEU-Z | 0.535 0(0.433 8~0.636 2) | 1 757.50 | 57.53 | 49.09 |
CRP | 0.578 5(0.480 0~0.676 9) | 61.00 g·L-1 | 61.64 | 56.36 |
WBC计数 | 0.548 1(0.444 4~0.651 7) | 10.08×109·L-1 | 64.38 | 47.27 |
NEUT# | 0.562 8(0.459 5~0.666 0) | 7.24×109·L-1 | 60.27 | 49.09 |
[1] | FLEISCHMANN C, SCHERAG A, ADHIKARI N K, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations[J]. Am J Respir Crit Care Med, 2016, 193(3):259-272. |
[2] |
VAN DER POLL T, VAN DER VEERDONK F L, SCICLUNA B P, et al. The immunopathology of sepsis and potential therapeutic targets[J]. Nat Rev Immunol, 2017, 17(7):407-420.
DOI PMID |
[3] | SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock(sepsis-3)[J]. JAMA, 2016, 315(8):801-810. |
[4] | GARNACHO-MONTERO J, GARCIA-GARMENDIA J L, BARRERO-ALMODOVAR A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis[J]. Crit Care Med, 2003, 31(12):2742-2751. |
[5] | BERMEJO-MARTIN J F, MARTIN-FERNANDEZ M, LOPEZ-MESTANZA C, et al. Shared features of endothelial dysfunction between sepsis and its preceding risk factors(aging and chronic disease)[J]. J Clin Med, 2018, 7(11):400. |
[6] |
KUMAR A, ROBERTS D, WOOD K E, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J]. Crit Care Med, 2006, 34(6):1589-1596.
DOI PMID |
[7] | SEOK Y, CHOI J R, KIM J, et al. Delta neutrophil index:a promising diagnostic and prognostic marker for sepsis[J]. Shock, 2012, 37(3):242-246. |
[8] | WACKER C, PRKNO A, BRUNKHORST F M, et al. Procalcitonin as a diagnostic marker for sepsis:a systematic review and meta-analysis[J]. Lancet Infect Dis, 2013, 13(5):426-435. |
[9] | CUI N, ZHANG H, CHEN Z, et al. Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock:retrospective analysis of 59 cases[J]. J Int Med Res, 2019, 47(4):1573-1579. |
[10] |
URRECHAGA E, BOVEDA O, AGUIRRE U. Role of leucocytes cell population data in the early detection of sepsis[J]. J Clin Pathol, 2018, 71(3):259-266.
DOI PMID |
[11] | BORREGAARD N. Neutrophils,from marrow to microbes[J]. Immunity, 2010, 33(5):657-670. |
[12] | AL-GWAIZ L A, BABAY H H. The diagnostic value of absolute neutrophil count,band count and morphologic changes of neutrophils in predicting bacterial infections[J]. Med Princ Pract, 2007, 16(5):344-347. |
[13] | OCUIN L M, BAMBOAT Z M, BALACHANDRAN V P, et al. Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis[J]. J Leukoc Biol, 2011, 89(3):423-432. |
[14] |
MATHY K A, KOEPKE J A. The clinical usefulness of segmented vs. stab neutrophil criteria for differential leukocyte counts[J]. Am J Clin Pathol, 1974, 61(6):947-958.
PMID |
[15] | KLEBANOFF S J. Myeloperoxidase:friend and foe[J]. J Leukoc Biol, 2005, 77(5):598-625. |
[16] |
ZIMMERMANN M, CREMER M, HOFFMANN C, et al. Granularity index of the SYSMEX XE-5000 hematology analyzer as a replacement for manual microscopy of toxic granulation neutrophils in patients with inflammatory diseases[J]. Clin Chem Lab Med, 2011, 49(7):1193-1198.
DOI PMID |
[17] | LE ROUX G, VLAD A, ECLACHE V, et al. Routine diagnostic procedures of myelodysplastic syndromes:value of a structural blood cell parameter(NEUT-X)determined by the Sysmex XE-2100[J]. Int J Lab Hematol, 2010, 32(6 Pt 1):e237-e243. |
[18] |
FURUNDARENA J R, ARAIZ M, URANGA M, et al. The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes[J]. Int J Lab Hematol, 2010, 32(3):360-366.
DOI PMID |
[19] | WU S C, LIANG C X, ZHANG Y L, et al. Elevated serum procalcitonin level in patients with chronic kidney disease without infection:a case-control study[J]. J Clin Lab Anal, 2020, 34(2):e23065. |
[20] |
ZHENG W, LIANG X, SHUI L, et al. Serum procalcitonin correlates with renal function in hepatitis B virus-related acute-on-chronic liver failure[J]. Cell Physiol Biochem, 2018, 50(5):1794-1803.
DOI PMID |
[21] | JEEHA R, SKINNER D L, DE VASCONCELLOS K, et al. Serum procalcitonin levels predict acute kidney injury in critically ill patients[J]. Nephrology(Carlton), 2018, 23(12):1090-1095. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||